GXGX GX Acquisiton Corp. - Class A

GX Acquisition Corp. is a blank check company. It was formed for the purpose of effectuating a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other similar business combination with one or more businesses. The company was founded on August 24, 2018 and is headquartered in New York, NY.  This company has other shares of common stock that are publicly traded. See the "related symbols" tab.

On 1/8/2021 the company announced a pending merger with Celularity Inc., a clinical-stage biotechnology company, leading the next evolution in cellular medicine with the development of off-the-shelf allogeneic therapies derived from the postpartum human placenta  

$10.20  +2.18 (27.18%)
As of 07/16/2021 16:00:00 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Financials
Industry:  Shell Companies
Index country:  USA
Country of incorporation:  
IPO date:  07/15/2019
Outstanding shares:  28,750,000
Average volume:  1,675,082
Market cap:   $293,250,000
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    36251A107
ISIN:        
Sedol:      
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   15.32
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy